FR2363329A1 - Compositions renfermant du 4-carbamoyl-5-hydroxyimidazole, utiles comme agent pour le traitement de cancers, de rhumatismes et de nephrites - Google Patents

Compositions renfermant du 4-carbamoyl-5-hydroxyimidazole, utiles comme agent pour le traitement de cancers, de rhumatismes et de nephrites

Info

Publication number
FR2363329A1
FR2363329A1 FR7727134A FR7727134A FR2363329A1 FR 2363329 A1 FR2363329 A1 FR 2363329A1 FR 7727134 A FR7727134 A FR 7727134A FR 7727134 A FR7727134 A FR 7727134A FR 2363329 A1 FR2363329 A1 FR 2363329A1
Authority
FR
France
Prior art keywords
nephritis
rheumatism
carbamoyl
treat cancer
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7727134A
Other languages
English (en)
Other versions
FR2363329B1 (fr
Inventor
Noboru Yoshida
Takao Kiyohara
Shigeo Ogino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of FR2363329A1 publication Critical patent/FR2363329A1/fr
Application granted granted Critical
Publication of FR2363329B1 publication Critical patent/FR2363329B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Applications thérapeutiques de 4-carbamoyl-5-hydroxyimidazole. Ce produit qui peut être représenté par la formule suivante :
FR7727134A 1976-09-07 1977-09-07 Compositions renfermant du 4-carbamoyl-5-hydroxyimidazole, utiles comme agent pour le traitement de cancers, de rhumatismes et de nephrites Granted FR2363329A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51107520A JPS604802B2 (ja) 1976-09-07 1976-09-07 制癌剤

Publications (2)

Publication Number Publication Date
FR2363329A1 true FR2363329A1 (fr) 1978-03-31
FR2363329B1 FR2363329B1 (fr) 1981-01-23

Family

ID=14461270

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7727134A Granted FR2363329A1 (fr) 1976-09-07 1977-09-07 Compositions renfermant du 4-carbamoyl-5-hydroxyimidazole, utiles comme agent pour le traitement de cancers, de rhumatismes et de nephrites

Country Status (6)

Country Link
JP (1) JPS604802B2 (fr)
AU (1) AU509455B2 (fr)
CA (1) CA1078736A (fr)
DE (1) DE2740281A1 (fr)
FR (1) FR2363329A1 (fr)
NL (1) NL7709853A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401916A1 (fr) * 1977-09-06 1979-03-30 Sumitomo Chemical Co Nouveaux derives de 5-hydroxy-1h-imidazole-4-carboxamide substitues en position 2, leur procede de production et composition pharmaceutique les contenant

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5495568A (en) * 1978-01-06 1979-07-28 Sumitomo Chem Co Ltd Novel imidazoleacetic acid derivative
AU530916B2 (en) * 1979-08-08 1983-08-04 Sumitomo Chemical Company, Limited 4-carbamoyl imidazolium-5-olate derivatives
EP0051962B1 (fr) * 1980-11-05 1988-08-24 Sumitomo Chemical Company, Limited Composition pharmaceutique contenant du 4-carbamoyl-imidazolium-5-olate
JPS5780317A (en) * 1980-11-05 1982-05-19 Sumitomo Chem Co Ltd Preparation of pharmaceutical composition for injection
US4464531A (en) * 1981-04-20 1984-08-07 Sumitomo Chemical Company, Limited 4-Carbamoylimidazolium-5-olate derivatives
JPS6089418A (ja) * 1983-10-20 1985-05-20 Sumitomo Chem Co Ltd 徐放性制癌剤
JPS60193997A (ja) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法
KR100675995B1 (ko) * 1998-11-13 2007-01-29 엘파트로닉 아게 관의 용접 방법 및 그 용접 방법을 수행하는 장치
JP5266010B2 (ja) 2007-09-14 2013-08-21 富士フイルム株式会社 4−カルバモイル−5−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物
RU2642670C2 (ru) 2013-01-15 2018-01-25 Фуджифилм Корпорэйшн Упакованный продукт твердого препарата, содержащего 5-гидрокси-1н-имидазол-4-карбоксамид или его соль, или его гидрат
RU2654703C2 (ru) 2013-01-15 2018-05-22 Фуджифилм Корпорэйшн Таблетки, содержащие 5-гидрокси-1н-имидазол-4-карбоксамид
EP2947069B1 (fr) * 2013-01-15 2017-11-22 FUJIFILM Corporation Sulfate de 5-hydroxy-1h-imidazole-4-carboxamide
KR101856889B1 (ko) 2014-01-10 2018-05-10 후지필름 가부시키가이샤 5-하이드록시-1h-이미다졸-4-카복사마이드의 유효 투여량 또는 감수성의 예측 방법 및 예측 장치, 잔토신 1인산의 양의 측정 방법 그리고 골수 이형성 증후군의 처치제 및 처치 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52101855A (en) * 1976-02-21 1977-08-26 Toyo Seisakusho Kk Air moistener

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401916A1 (fr) * 1977-09-06 1979-03-30 Sumitomo Chemical Co Nouveaux derives de 5-hydroxy-1h-imidazole-4-carboxamide substitues en position 2, leur procede de production et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
DE2740281A1 (de) 1978-03-09
CA1078736A (fr) 1980-06-03
JPS5332124A (en) 1978-03-27
AU509455B2 (en) 1980-05-15
JPS604802B2 (ja) 1985-02-06
FR2363329B1 (fr) 1981-01-23
AU2861977A (en) 1979-03-15
NL7709853A (nl) 1978-03-09

Similar Documents

Publication Publication Date Title
FR2363329A1 (fr) Compositions renfermant du 4-carbamoyl-5-hydroxyimidazole, utiles comme agent pour le traitement de cancers, de rhumatismes et de nephrites
ATE99942T1 (de) Dehydrocholecalciferolderivate.
FR2318649A1 (fr) Medicament pour le traitement des rhumatismes et cancers
GB1364284A (en) Acylaminophyrrolidinone derivatives their preparation and pharma ceutical compositions containing them
ES455721A1 (es) Procedimiento para la preparacion de una nueva sal de pipe- raziniluracilo.
FR2450835A2 (fr) Derives de la tetrahydroalstonine et leur application en therapeutique
GB1230705A (fr)
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
GB1410349A (en) Lysergic acid derivatives
FR2320098A1 (fr) Nouveaux derives de la thiazilo (3,4-b) isoquinoleine, leur preparation et les compositions qui les contiennent
JPS55167221A (en) Anticancer drug
JPS5675432A (en) Antitumor agent containing ethyl piperidylacetylaminobenzoate
FR2129914A2 (en) Sulphonic acid salts of aliphatic diamines - with antiviral activity
ES442375A1 (es) Un procedimiento para la preparacion de 10,11-dihidro-3-car-boxiciproheptadina y su n-oxido.
GB1395929A (en) Thioureas
FR2244501A1 (en) 5-Chloro-3-formyl-2-methylindoles - with diuretic analgesic and antiinflammatory activity
GB1298057A (en) Bis(aminoalkylsulphamoyl)anthraquinones
FR2351655A1 (fr) Nouveau derive de la thiazolo (3,4-b) isoquinoleine, sa preparation et les compositions qui le contiennent
FR2269334A1 (en) Anti-allergic 2-cyanoindanes and 3-cyanocoumarins - for prophylaxis and treatment of asthma, hay-fever and rhinitis
GB1345319A (en) Pharmaceutically active thioalkylamine
ES369286A1 (es) Procedimiento para la preparacion de nuevos compuestos de pirimidina cuaternatios que contienen zinc.
JPS5629600A (en) Novel 2-fluoro-n6,o2'-diacyl-adenosine-3',5'-cyclic phosphate, its preparation, and carcinostatic agent containing the same
FR2204407A1 (en) 2-Hydroxymethyl-1-phenylimidazolines - with analgesic, antiinflammatory, vasodilatory, anticholinergic and spasmolytic activity
FR2456098A2 (fr) Nouveaux derives de l'isoquinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent
GB1228185A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse